in this issue
EnviroTech :: Alternative fuels
Amyris Builds Post-IPO Momentum
11:44 AM MDT | October 6, 2011 | Rebecca Coons
Synthetic biology firm Amyris (Emeryville, CA) continues to accrue an impressive list of partners as it ramps up production of farnesene, a versatile C15 hydrocarbon and the company’s first commercial product. Founded in 2003, Amyris originally set out to develop yeast that would produce a precursor to artemisinin, a potent anti-malaria drug whose production volumes were limited by a long process time. After that project was turned over royalty-free to sanofi-aventis for larger-scale development, Amyris shifted its attention to the other value compounds its...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee